These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8639771

  • 21. Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow.
    Verfaillie CM, Almeida-Porada G, Wissink S, Zanjani ED.
    Exp Hematol; 2000 Sep; 28(9):1071-9. PubMed ID: 11008020
    [Abstract] [Full Text] [Related]

  • 22. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
    Hess NJ, Lindner PN, Vazquez J, Grindel S, Hudson AW, Stanic AK, Ikeda A, Hematti P, Gumperz JE.
    Front Immunol; 2020 Sep; 11():573406. PubMed ID: 33193358
    [Abstract] [Full Text] [Related]

  • 23. Analysis of human hematopoietic stem cell populations.
    Murray L, DiGiusto D, Chen B, Chen S, Combs J, Conti A, Galy A, Negrin R, Tricot G, Tsukamoto A.
    Blood Cells; 1994 Sep; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [Abstract] [Full Text] [Related]

  • 24. Induction of c-kit molecules on human CD34+/c-kit < low cells: evidence for CD34+/c-kit < low cells as primitive hematopoietic stem cells.
    Sogo S, Inaba M, Ogata H, Hisha H, Adachi Y, Mori S, Toki J, Yamanishi K, Kanzaki H, Adachi M, Ikehara S.
    Stem Cells; 1997 Sep; 15(6):420-9. PubMed ID: 9402654
    [Abstract] [Full Text] [Related]

  • 25. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
    Haas R, Möhle R, Pförsich M, Fruehauf S, Witt B, Goldschmidt H, Hunstein W.
    Blood; 1995 Apr 01; 85(7):1936-43. PubMed ID: 7535595
    [Abstract] [Full Text] [Related]

  • 26. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB, Haylock DN, Dowse T, Simmons PJ, Trimboli S, Ashman LK, Juttner CA.
    Blood; 1994 Nov 01; 84(9):2930-9. PubMed ID: 7524760
    [Abstract] [Full Text] [Related]

  • 27. Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.
    Sutherland DR, Yeo EL, Stewart AK, Nayar R, DiGiusto R, Zanjani E, Hoffman R, Murray LJ.
    Exp Hematol; 1996 Jun 01; 24(7):795-806. PubMed ID: 8647230
    [Abstract] [Full Text] [Related]

  • 28. Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep.
    Srour EF, Zanjani ED, Cornetta K, Traycoff CM, Flake AW, Hedrick M, Brandt JE, Leemhuis T, Hoffman R.
    Blood; 1993 Dec 01; 82(11):3333-42. PubMed ID: 7694681
    [Abstract] [Full Text] [Related]

  • 29. A murine model for human cord blood transplantation: near-term fetal and neonatal peripheral blood cells can achieve long-term bone marrow engraftment in sublethally irradiated adult recipients.
    Scaradavou A, Isola L, Rubinstein P, Galperin Y, Najfeld V, Berlin D, Gordon J, Weinberg RS.
    Blood; 1997 Feb 01; 89(3):1089-99. PubMed ID: 9028342
    [Abstract] [Full Text] [Related]

  • 30. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution.
    Dao MA, Arevalo J, Nolta JA.
    Blood; 2003 Jan 01; 101(1):112-8. PubMed ID: 12393633
    [Abstract] [Full Text] [Related]

  • 31. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
    Hoffman R, Tong J, Brandt J, Traycoff C, Bruno E, McGuire BW, Gordon MS, McNiece I, Srour EF.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():76-82. PubMed ID: 7691331
    [Abstract] [Full Text] [Related]

  • 32. Expansion of cord blood progenitors and use for hemopoietic reconstitution.
    Gabutti V, Timeus F, Ramenghi U, Crescenzio N, Marranca D, Miniero R, Cornaglia G, Bagnara GP.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():105-12. PubMed ID: 7691315
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
    Bernstein ID, Andrews RG, Zsebo KM.
    Blood; 1991 Jun 01; 77(11):2316-21. PubMed ID: 1710148
    [Abstract] [Full Text] [Related]

  • 39. Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c-kit protein.
    Sonoda Y, Kimura T, Sakabe H, Tanimukai S, Ohmizono Y, Nakagawa S, Yokota S, Lyman SD, Abe T.
    Eur J Haematol; 1997 Apr 01; 58(4):257-64. PubMed ID: 9186537
    [Abstract] [Full Text] [Related]

  • 40. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood.
    Shields LE, Andrews RG.
    Am J Obstet Gynecol; 1998 May 01; 178(5):931-7. PubMed ID: 9609562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.